EGRX
Eagle Pharmaceuticals Inc
A specialty pharmaceutical company that develops injectable medicines by reformulating proven drugs into easier-to-use versions. Its products include BENDEKA and BELRAPZO for chronic lymphocytic leukemia, and RYANODEX, a treatment for a rare, life-threatening anesthesia reaction called malignant hyperthermia. Founded in 2007 by Scott Tarriff, the company improved on existing medicines rather than inventing new molecules from scratch, and its version of RYANODEX can be mixed up in under a minute during an emergency.
CUSIP: 269796108HealthcareUS1 holder